Fading	O
With	O
Time	O
of	O
PD	O
-	O
L1	O
Immunoreactivity	O
in	O
Non-Small	B:C0007131
Cells	I:C0007131
Lung	I:C0007131
Cancer	I:C0007131
Tissues	O
:	O
A	O
Methodological	O
Study	O
.	O

Fading	O
With	O
Time	O
of	O
PD	O
-	O
L1	O
Immunoreactivity	O
in	O
Non-Small	O
Cells	I:C0007131
Lung	I:C0007131
Cancer	I:C0007131
Tissues	B:C0040300
:	O
A	O
Methodological	O
Study	O
.	O

Blockade	O
of	O
inhibitory	B:C1155874
immune	I:C1155874
checkpoints	I:C1155874
is	O
currently	O
arising	O
as	O
a	O
potential	O
immunologic	O
option	O
for	O
tumor	O
therapy	I:C0920425
.	O

Blockade	O
of	O
inhibitory	O
immune	I:C1155874
checkpoints	I:C1155874
is	O
currently	O
arising	O
as	O
a	O
potential	O
immunologic	O
option	O
for	O
tumor	B:C0920425
therapy	I:C0920425
.	O

Inhibition	O
of	O
programmed	B:C2986635
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	B:C0023688
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	B:C0008976
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	B:C0025202
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	B:C0007131
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	B:C0007131
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	B:C0005695
and	O
kidney	O
cancer	I:C1378703
.	O

Inhibition	O
of	O
programmed	O
cell	I:C2986635
death	I:C2986635
protein	I:C2986635
1	I:C2986635
and	O
/	O
or	O
its	O
specific	O
ligand	O
programmed	O
death	O
-	O
ligand	O
1	O
(	O
PD	O
-	O
L1	O
)	O
was	O
effective	O
in	O
clinical	O
trials	I:C0008976
in	O
advanced	O
melanoma	O
,	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	O
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
bladder	O
and	O
kidney	B:C1378703
cancer	I:C1378703
.	O

The	O
predictive	O
role	O
of	O
the	O
immunohistochemical	O
(	O
IHC	O
)	O
expression	B:C1171362
of	O
PD	O
-	O
L1	O
is	O
highly	O
debated	O
.	O

Different	O
reagents	B:C0034760
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	B:C1522642
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	B:C0007634
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	B:C1171362
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	B:C0438231
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	B:C0014597
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	B:C0024264
are	O
the	O
main	O
issue	O
.	O

Different	O
reagents	O
,	O
clones	O
,	O
cutoffs	O
of	O
cell	O
expression	O
and	O
subjective	O
interpretation	O
of	O
PD	O
-	O
L1	O
immunoreactivity	O
in	O
epithelial	O
cells	I:C0014597
and	O
lymphocytes	O
are	O
the	O
main	O
issue	B:C0033213
.	O

In	O
this	O
study	O
we	O
selected	O
58	O
consecutive	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
surgical	O
specimens	I:C1292533
that	O
underwent	O
pathologic	O
examination	I:C4086729
from	O
January	O
2014	O
to	O
July	O
2015	O
.	O

In	O
this	O
study	O
we	O
selected	O
58	O
consecutive	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
surgical	B:C1292533
specimens	I:C1292533
that	O
underwent	O
pathologic	O
examination	I:C4086729
from	O
January	O
2014	O
to	O
July	O
2015	O
.	O

In	O
this	O
study	O
we	O
selected	O
58	O
consecutive	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
surgical	O
specimens	I:C1292533
that	O
underwent	O
pathologic	B:C4086729
examination	I:C4086729
from	O
January	O
2014	O
to	O
July	O
2015	O
.	O

Using	O
a	O
tissue	O
microarray	B:C1449575
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	B:C0079722
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	B:C0597032
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	B:C0597032
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	B:C1516204
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	B:C0919553
and	O
the	O
age	O
of	O
the	O
tissue	O
blocks	I:C0040300
.	O

Using	O
a	O
tissue	O
microarray	O
approach	I:C1449575
we	O
evaluated	O
the	O
IHC	O
expression	O
of	O
PD	O
-	O
L1	O
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
and	O
tumor	O
cells	I:C0597032
(	O
tumor	O
cells	I:C0597032
)	O
and	O
compared	O
the	O
ICH	O
staining	O
with	O
tumor	O
histology	I:C1516204
,	O
grade	O
and	O
the	O
age	O
of	O
the	O
tissue	B:C0040300
blocks	I:C0040300
.	O

The	O
main	O
new	O
finding	B:C0243095
was	O
the	O
fading	O
of	O
PD	O
-	O
L1	O
IHC	O
expression	O
in	O
tumor	O
cells	I:C0597032
in	O
tissues	O
processed	O
in	O
2014	O
compared	O
with	O
2015	O
.	O

The	O
main	O
new	O
finding	O
was	O
the	O
fading	O
of	O
PD	O
-	O
L1	O
IHC	O
expression	O
in	O
tumor	B:C0597032
cells	I:C0597032
in	O
tissues	O
processed	O
in	O
2014	O
compared	O
with	O
2015	O
.	O

The	O
main	O
new	O
finding	O
was	O
the	O
fading	O
of	O
PD	O
-	O
L1	O
IHC	O
expression	O
in	O
tumor	O
cells	I:C0597032
in	O
tissues	B:C0040300
processed	O
in	O
2014	O
compared	O
with	O
2015	O
.	O

PD	O
-	O
L1	O
expression	B:C0017262
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
in	O
the	O
2	O
years	O
was	O
similar	O
.	O

PD	O
-	O
L1	O
expression	O
in	O
tumor	B:C0079722
-	I:C0079722
infiltrating	I:C0079722
lymphocytes	I:C0079722
in	O
the	O
2	O
years	O
was	O
similar	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	B:C0597032
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	O
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	O
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	B:C0007137
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	O
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	B:C0449574
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	O
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	B:C0019638
and	O
the	O
adenocarcinoma	O
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	B:C0001418
histology	O
(	O
P=0.013	O
)	O
.	O

We	O
also	O
found	O
a	O
significant	O
higher	O
immunoreactivity	O
of	O
tumor	O
cells	I:C0597032
in	O
high	O
grade	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
and	O
in	O
the	O
squamous	O
carcinoma	I:C0007137
histotype	O
compared	O
with	O
low	O
grade	O
tumors	O
and	O
the	O
adenocarcinoma	O
histology	B:C0019638
(	O
P=0.013	O
)	O
.	O

We	O
demonstrated	O
that	O
the	O
IHC	O
evaluation	O
of	O
PD	O
-	O
L1	O
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
archival	O
tissues	I:C0040300
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	O
setting	I:C0030664
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	O
blocks	I:C0040300
older	O
than	O
1	O
year	O
.	O

We	O
demonstrated	O
that	O
the	O
IHC	O
evaluation	O
of	O
PD	O
-	O
L1	O
in	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
archival	B:C0040300
tissues	I:C0040300
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	O
setting	I:C0030664
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	O
blocks	I:C0040300
older	O
than	O
1	O
year	O
.	O

We	O
demonstrated	O
that	O
the	O
IHC	O
evaluation	O
of	O
PD	O
-	O
L1	O
in	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
archival	O
tissues	I:C0040300
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	B:C0030664
setting	I:C0030664
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	O
blocks	I:C0040300
older	O
than	O
1	O
year	O
.	O

We	O
demonstrated	O
that	O
the	O
IHC	O
evaluation	O
of	O
PD	O
-	O
L1	O
in	O
non-small	O
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
archival	O
tissues	I:C0040300
is	O
feasible	O
and	O
can	O
be	O
implemented	O
in	O
a	O
routine	O
pathology	O
setting	I:C0030664
,	O
but	O
it	O
should	O
be	O
carefully	O
assessed	O
in	O
tissue	B:C0040300
blocks	I:C0040300
older	O
than	O
1	O
year	O
.	O

